share_log

百利天恒(688506.SH):收到8亿美元有关BL-B01D1项目首付款

Baili Tianheng (688506.SH): Received US$800 million down payment for BL-B01D1 project

Zhitong Finance ·  Mar 10 03:45

Zhitong Finance App News, Bailey Tianheng (688506.SH) announced that on December 11, 2023, SysTimMune, Inc.'s wholly-owned subsidiary SysTimMune, Inc. and Bristol-Myers Squibb (“BMS”, NYSE code: BMY) reached an exclusive license and cooperation agreement for the BL-B01D1 (EGFR×HER3 dual-antibody ADC) project. On February 8, 2024, the cooperation agreement officially came into effect.

As of March 7, 2024, the company has received a down payment of 800 million US dollars from BMS (the actual payment amount is subject to bank charges), and the company expects this payment to have a positive impact on the 2024 results.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment